Elekta (OTCMKTS:EKTAY) Shares Gap Up – Still a Buy?

Elekta AB (OTCMKTS:EKTAY)’s stock price gapped up before the market opened on Wednesday. The stock had previously closed at $5.09, but opened at $5.2850. Elekta shares last traded at $5.28, with a volume of 2,088 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded shares of Elekta from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 28th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, the company currently has a consensus rating of “Hold”.

Elekta Stock Performance

The business’s fifty day moving average price is $5.34 and its 200-day moving average price is $5.51. The stock has a market cap of $1.95 billion, a PE ratio of -44.00 and a beta of 1.03. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.62 and a current ratio of 0.86.

Elekta (OTCMKTS:EKTAY) last issued its earnings results on Thursday, August 27th. The company reported $0.07 earnings per share (EPS) for the quarter. The company had revenue of $372.30 million for the quarter. Elekta had a negative net margin of 2.38% and a positive return on equity of 13.47%. As a group, equities research analysts forecast that Elekta AB will post 0.43 EPS for the current fiscal year.

Elekta Company Profile

Elekta AB is a Sweden-based medical technology company that develops and supplies equipment, software and related services for radiation oncology and neurosurgery. Its technologies are used by hospitals and cancer treatment centers to plan and deliver precision radiation treatments for patients with cancer and neurological disorders.

The company’s portfolio includes linear accelerators, stereotactic radiosurgery systems, brachytherapy solutions, treatment-planning and oncology information software, and magnetic resonance-guided radiation therapy technology.